Clarithromycin as a “Repurposing Drug” Against MALT Lymphoma

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14878
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Conjunctival MALT Lymphoma

Clinical Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Drug Repurposing Is a New Opportunity for Developing Drugs Against Neuropsychiatric Disorders

Schizophrenia Research and Treatment
PsychiatryMental HealthNeurology
2016English

Conjunctival CD5+ MALT Lymphoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Toward Repurposing Ciclopirox as an Antibiotic Against Drug-Resistant Acinetobacter Baumannii, Escherichia Coli, and Klebsiella Pneumoniae

PLoS ONE
Multidisciplinary
2013English

Drug Repurposing as an Efficient Strategy in Drug Development – Example of CNS Area

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Repurposing a Platelet Aggregation Inhibitor Ticagrelor as an Antimicrobial Against Clostridioides Difficile

Scientific Reports
Multidisciplinary
2020English

Sequential Occurrence of a Splenic Marginal Zone Lymphoma, Extranodal MALT Lymphoma, and Hodgkin Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Drug Repurposing in Parkinson’s Disease

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2018English

A Rare Case of MALT Lymphoma Underlying Ileocecal Intussusception

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy